MANCIA GIUSEPPE

Ruolo:
Professore emerito

Pubblicazioni

  • Rea, F., Corrao, G., Mancia, G. (2024). Risk of Dementia During Antihypertensive Drug Therapy in the Elderly. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 83(13 (2 April 2024)), 1194-1203 [10.1016/j.jacc.2024.01.030]. Dettaglio

  • Kreutz, R., Palatini, P., Stergiou, G., Mancia, G. (2024). Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?. JOURNAL OF HYPERTENSION, 42(1), 188-189 [10.1097/HJH.0000000000003618]. Dettaglio

  • Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Kjeldsen, S., et al. (2024). Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines. HYPERTENSION [10.1161/HYPERTENSIONAHA.124.22821]. Dettaglio

  • Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M., et al. (2024). Rationale of treatment recommendations in the 2023 ESH hypertension guidelines. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 121(March 2024), 4-8 [10.1016/j.ejim.2023.12.015]. Dettaglio

  • Rist, A., Sevre, K., Wachtell, K., Devereux, R., Aurigemma, G., Smiseth, O., et al. (2024). The current best drug treatment for hypertensive heart failure with preserved ejection fraction. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 120(February 2024), 3-10 [10.1016/j.ejim.2023.10.008]. Dettaglio

Progetti di ricerca

EU-MASCARA-Markers for Sub-Clinical Cardiovascular Risk Assessemnt
Anno: 2011
Bando: 2011-014 - HEALTH.2011.2.4.2-2
Enti finanziatori: UNIONE EUROPEA
Network Enabled Drug Design
Anno: 2009
Bando: 2009-007 - Bando Fondo per la promozione di accordi istituzionali, Bando accordi istituzionali
Integrating Genomics, clinical Research and care Hypertension
Anno: 2005
Bando: FP6-LIFESCIHEALTH Life sciences, genomics and biotechnology for health,LSH-2005-2.1.1-2 Hypertension and cardiovascular disease